This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply 4,566,025 units of the drug febuxostat 40 mg tablets. The delivery order contract, valued at $1,624.68, has a firm fixed price and an ultimate completion date of October 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of febuxostat 40 mg tablets. The contract has a firm fixed price, with a ceiling value of $1,273.48, and a period of performance ending on June 23, 2025. The contract is not set aside and was awarded on June 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,008.52, is for the delivery of Febuxostat 80mg tablets to support federal healthcare programs. The contract has a period of performance through March 31, 2025 and uses a firm fixed price pricing structure. This award is a task order under Amerisourcebergen's larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,661,577 units of febuxostat 40 mg tablets. The award, valued at $2,066.16, is a Firm Fixed Price Delivery Order with an ultimate completion date of December 10, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen, a for-profit organization registered in the System for Award Management...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for 4,565,296,599 units of Febuxostat 40 mg Tablets in 30-count packages. The contract has a ceiling value of $1,928.52 and is a Firm Fixed Price arrangement. It was awarded on July 30, 2024 with a performance period through July 31, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier, to provide FEBUXOSTAT 40 MG TABLET 30S. The fixed-price contract has a ceiling value of $1,138.50 and an ultimate completion date of July 8, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication FEBUXOSTAT 40 MG TABLET 30S and has a ceiling value of $1,848.50. It is a firm fixed price delivery order contract with a completion date of May 23, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of febuxostat 40 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,075.98 and an ultimate completion date of April 14, 2025. There was no set-aside designation for this award. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of FEBUXOSTAT 40 MG TABLET 30S. The contract has a firm fixed price of $1,372.43 and a completion date of June 10, 2025. AmerisourceBergen Drug Corporation is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including DLA. The contract is not set aside...
This federal contract award, with an ID of SPE2DB22D3016|SPE2DB25FAMN5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,802.68 firm fixed-price delivery order is for the supply of 4567201573 - FEBUXOSTAT 40 MG TABLET 30S, with a completion date of February 7, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...